Polycystic kidney disease - Where gene dosage counts

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Eccles, Michael R ^a   Stayner, Cherie A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BASOLATERAL MEMBRANE; CELL ADHESION; EPITHELIUM CELL; EUKARYOTIC FLAGELLUM; GENE; GENE DOSAGE; GENE MUTATION; GENE REGULATORY NETWORK; GERMLINE MUTATION; HUMAN; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; NOTE; PHENOTYPE; SOMATIC MUTATION;

EID: 84899732813     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-24     Document Type: Note

References (39)

1. Wilson PD: Polycystic kidney disease. N Engl J Med 2004, 350:151-64.
2. Igarashi P, Somlo S: Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol 2002, 13:2384-98. (Pubitemid 34925250)
3. Guay-Woodford LM: Renal cystic diseases: diverse phenotypes converge on the cilium/centrosome complex. Pediatr Nephrol 2006, 21:1369-76.
4. Bisceglia M, Galliani CA, Senger C, Stallone C, Sessa A: Renal cystic diseases: a review. Adv Anat Pathol 2006, 13:26-56. (Pubitemid 44357146)
5. Zerres K, Mücher G, Becker J, Steinkamm C, Rudnik-Schöneborn S, Heikkilä P, Rapola J, Salonen R, Germino GG, Onuchic L, Somlo S, Avner ED, Harman LA, Stockwin JM, Guay-Woodford LM: Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet 1998, 76:137-44. (Pubitemid 28117131)
6. Mochizuki T, Tsuchiya K, Nitta K: Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies. Clin Exp Nephrol 2013, 17:317-26.
7. Bae K, Park B, Sun H, Wang J, Tao C, Chapman AB, Torres VE, Grantham JJ, Mrug M, Bennett WM, Flessner MF, Landsittel DP, Bae KT: Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2013, 8:1089-97.
8. Torra R, Badenas C, Darnell A, Nicolau C, Volpini V, Revert L, Estivill X: Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol 1996, 7:2142-51. (Pubitemid 27468243)
9. Reeders ST: Multilocus polycystic disease. Nat Genet 1992, 1:235-7.
10. Pei Y: A "two-hit" model of cystogenesis in autosomal dominant polycystic kidney disease? Trends Mol Med 2001, 7:151-6.
11. Qian F, Watnick TJ, Onuchic LF, Germino GG: The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996, 87:979-87. (Pubitemid 26427982)
12. Watnick T, He N,Wang K, Liang Y, Parfrey P, Hefferton D, St George-Hyslop P, Germino G, Pei Y: Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations. Nat Genet 2000, 25:143-4. (Pubitemid 30394981)
13. Koptides M, Mean R, Demetriou K, Pierides A, Deltas CC: Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease. Hum Mol Genet 2000, 9:447-52. (Pubitemid 30098739)
14. Wu G, D'Agati V, Cai Y, Markowitz G, Park JH, Reynolds DM, Maeda Y, Le TC, Hou H, Kucherlapati R, Edelmann W, Somlo S: Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 1998, 93:177-88. (Pubitemid 28180852)
15. Lanoix J, D'Agati V, Szabolcs M, Trudel M: Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD). Oncogene 1996, 13:1153-60. (Pubitemid 26343568)
16. Ong AC, Harris PC, Davies DR, Pritchard L, Rossetti S, Biddolph S, Vaux DJ, Migone N, Ward CJ: Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue. Kidney Int 1999, 56:1324-33. (Pubitemid 29451240)
17. Ward CJ, Turley H, Ong AC, Comley M, Biddolph S, Chetty R, Ratcliffe PJ, Gattner K, Harris PC: Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc Natl Acad Sci USA 1996, 93:1524-8. (Pubitemid 26075157)
18. Geng L, Segal Y, Peissel B, Deng N, Pei Y, Carone F, Rennke HG, Glücksmann-Kuis AM, Schneider MC, Ericsson M, Reeders ST, Zhou J: Identification and localization of polycystin, the PKD1 gene product. J Clin Invest 1996, 98:2674-82. (Pubitemid 26427391)
19. Lantinga-van Leeuwen IS, Dauwerse JG, Baelde HJ, Leonhard WN, van de Wal A, Ward CJ, Verbeek S, Deruiter MC, Breuning MH, de Heer E, Peters DJM: Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum Mol Genet 2004, 13:3069-77. (Pubitemid 40045261)
20. Jiang S, Chiou Y, Wang E, Lin H, Lin Y, Chi Y, Wang CL, Tang M, Li H: Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1. Am J Pathol 2006, 168:205-20. (Pubitemid 43062574)
21. Park EY, Sung YH, Yang MH, Noh JY, Park SY, Lee TY, Yook YJ, Yoo KH, Roh KJ, Kim I, Hwang Y, Oh GT, Seong JK, Ahn C, Lee H, Park JH: Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice. J Biol Chem 2009, 284:7214-22.
22. Kurbegovic A, Côté O, Couillard M, Ward CJ, Harris PC, Trudel M: Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes. Hum Mol Genet 2010, 19:1174-89.
23. Smith LA, Bukanov NO, Husson H, Russo RJ, Barry TC, Taylor AL, Beier DR, Ibraghimov-Beskrovnaya O: Development of polycystic kidney disease in juvenile cystic kidney mice: insights into pathogenesis, ciliary abnormalities, and common features with human disease. J Am Soc Nephrol 2006, 17:2821-31. (Pubitemid 44484672)
24. Rossetti S, Kubly VJ, Consugar MB, Hopp K, Roy S, Horsley SW, Chauveau D, Rees L, Barratt TM, van't Hoff WG, Niaudet P, Niaudet WP, Torres VE, Harris PC: Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int 2009, 75:848-55.
25. Vujic M, Heyer CM, Ars E, Hopp K, Markoff A, Orndal C, Rudenhed B, Nasr SH, Torres VE, Torra R, Bogdanova N, Harris PC: Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. J Am Soc Nephrol 2010, 21:1097-102.
26. Hopp K, Ward CJ, Hommerding CJ, Nasr SH, Tuan H, Gainullin VG, Rossetti S, Torres VE, Harris PC: Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J Clin Invest 2012, 122:4257-73.
27. Ahrabi AK, Terryn S, Valenti G, Caron N, Serradeil-Le Gal C, Raufaste D, Nielsen S, Horie S, Verbavatz J, Devuyst O: PKD1 haploinsufficiency causes a syndrome of inappropriate anti-diuresis in mice. J Am Soc Nephrol 2007, 18:1740-53. (Pubitemid 46870311)
28. Wang E, Hsieh-Li H, Chiou Y, Chien Y, Ho H, Chin H, Wang CL, Liang S, Jiang S: Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1. J Pathol 2010, 222:238-48.
29. Lantinga-van Leeuwen IS, Leonhard WN, van der Wal A, Breuning MH, de Heer E, Peters DJM: Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum Mol Genet 2007, 16:3188-96. (Pubitemid 350131335)
30. Piontek K, Menezes LF, Garcia-Gonzalez MA, Huso DL, Germino GG: A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med 2007, 13:1490-5. (Pubitemid 350224245)
31. Takakura A, Contrino L, Beck AW, Zhou J: Pkd1 inactivation induced in adulthood produces focal cystic disease. J Am Soc Nephrol 2008, 19:2351-63.
32. Patel V, Hajarnis S, Williams D, Hunter R, Huynh D, Igarashi P: MicroRNAs regulate renal tubule maturation through modulation of Pkd1. J Am Soc Nephrol 2012, 23:1941-8.
33. Fedeles SV, Tian X, Gallagher A, Mitobe M, Nishio S, Lee SH, Cai Y, Geng L, Crews CM, Somlo S: A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Nat Genet 2011, 43:639-47.
34. Freedman BS, Lam AQ, Sundsbak JL, Iatrino R, Su X, Koon SJ, Wu M, Daheron L, Harris PC, Zhou J, Bonventre JV: Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. J Am Soc Nephrol 2013, 24:1571-86.
35. Lu W, Peissel B, Babakhanlou H, Pavlova A, Geng L, Fan X, Larson C, Brent G, Zhou J: Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation. Nat Genet 1997, 17:179-81.
36. Stayner C, Iglesias DM, Goodyer PR, Ellis L, Germino G, Zhou J, Eccles MR: Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease. Hum Mol Genet 2006, 15:3520-8. (Pubitemid 44884119)
37. Qin S, Taglienti M, Cai L, Zhou J, Kreidberg JA: c-Met and NF-κB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease. J Am Soc Nephrol 2012, 23:1309-18.
38. Thivierge C, Kurbegovic A, Couillard M, Guillaume R, Coté O, Trudel M: Overexpression of PKD1 causes polycystic kidney disease. Mol Cell Biol 2006, 26:1538-48. (Pubitemid 43202577)
39. Li X: Epigenetics and autosomal dominant polycystic kidney disease. Biochim Biophys Acta 2011, 1812:1213-8.